Dr. Salmon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 East W.T. Harris Boulevard
1214
Charlotte, NC 28262Phone+1 704-863-6160Fax+1 704-863-6161- Is this information wrong?
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Virginia Medical CenterResidency, Internal Medicine, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2005 - 2024
TN State Medical License 2003 - 2006
VA State Medical License 1999 - 2002- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- A Study of Regorafenib in Advanced Pancreatic Cancer Patients Start of enrollment: 2014 Jun 06
Publications & Presentations
PubMed
- 10 citationsA Complete Pathological Response to Pembrolizumab following ex vivo Liver Resection in a Patient with Colorectal Liver Metastases.Maria Baimas-George, Erin H. Baker, Michal Kamionek, J. Stuart Salmon, A. Sastry, D. M. Levi, Dionisios Vrochides> ;Chemotherapy. 2018 Apr 5
- 46 citationsVeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P. Carbone, J. Stuart Salmon, Dean Billheimer, Heidi Chen, Alan B. Sandler, Heinrich Roder, Joanna Roder, Maxim Tsypin, Roy S. Herbst, Anne S. Tsao, Hai T. Tran,...> ;Lung Cancer. 2010 Sep 1
- VeriStrat predicts survival in patients with non-small cell lung cancer (NSCLC) treated with erlotinib and bevacizumab.Salmon JS, Dang TP, Billheimer D, Roder H, Grigorieva J, Tsypin M, Herbst RS, Tsao AS, Tran H, Carbone DP> ;J. Clin. Oncol.. 2008-05-20
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Atrium Health's Carolinas Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
